Lateral pelvic lymph node (LPLN) involvement occurs in 10%–25% of rectal cancer cases. Total mesorectal excision (TME) with routine LPLN dissection (LPLND) is predominantly applied in Japan whereas TME with… Click to show full abstract
Lateral pelvic lymph node (LPLN) involvement occurs in 10%–25% of rectal cancer cases. Total mesorectal excision (TME) with routine LPLN dissection (LPLND) is predominantly applied in Japan whereas TME with neoadjuvant treatment are used in the West. LPLND is a morbid procedure and minimally invasive techniques may help reduce its morbidity. Selective lateral pelvic node dissection with TME following neoadjuvant treatment achieves acceptable disease‐free and overall survival.
               
Click one of the above tabs to view related content.